Get access

Guidelines for management of Bowen's disease: 2006 update

Authors

  • N.H. Cox,

    1. Department of Dermatology, Cumberland Infirmary, Carlisle CA2 7HY, U.K.
      *Craigavon Area Hospital, Craigavon BT63 5QQ, U.K.
      †Stirling Royal Infirmary, Stirling FK8 2AU, U.K.
    Search for more papers by this author
  • D.J. Eedy,

    1. Department of Dermatology, Cumberland Infirmary, Carlisle CA2 7HY, U.K.
      *Craigavon Area Hospital, Craigavon BT63 5QQ, U.K.
      †Stirling Royal Infirmary, Stirling FK8 2AU, U.K.
    Search for more papers by this author
  • C.A. Morton,

    1. Department of Dermatology, Cumberland Infirmary, Carlisle CA2 7HY, U.K.
      *Craigavon Area Hospital, Craigavon BT63 5QQ, U.K.
      †Stirling Royal Infirmary, Stirling FK8 2AU, U.K.
    Search for more papers by this author
  • on behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee

    1. Department of Dermatology, Cumberland Infirmary, Carlisle CA2 7HY, U.K.
      *Craigavon Area Hospital, Craigavon BT63 5QQ, U.K.
      †Stirling Royal Infirmary, Stirling FK8 2AU, U.K.
    Search for more papers by this author

  • Conflicts of interest
    A statement is provided at the end of these guidelines.

  • Members of the British Association of Dermatologists Therapy Guidelines and Audit committee are A.D. Ormerod (Chairman), D.J. Eedy, D. Mitchell, F. Humphreys, J. Peters, R. Bull, H. Bell, M. Kouimtzi and S. Jones.

Neil Cox.
E-mail: neil.cox@ncumbria-acute.nhs.uk

Summary

This article represents a planned regular updating of the previous British Association of Dermatologists (BAD) guidelines for management of Bowen's disease. They have been prepared for dermatologists on behalf of the BAD. They present evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines.

Ancillary